<DOC>
	<DOCNO>NCT01517321</DOCNO>
	<brief_summary>This Phase III clinical trial examine safety , tolerability , efficacy addition MK-0431/ONO-5435 Japanese patient Type 2 Diabetes mellitus inadequate glycemic control diet/exercise therapy rapid-acting insulin secretagogue monotherapy .</brief_summary>
	<brief_title>MK-0431/ONO-5435 Phase III Clinical Trial-Rapid-acting Insulin Secretagogue Add-on Study Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Short-Acting</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Japanese patient Type 2 Diabetes Mellitus inadequate glycemic control diet/exercise therapy rapidacting insulin secretagogue monotherapy Patients Type 1 Diabetes Mellitus</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>